Viridian Therapeutics, Inc.

VRDNNASDAQ Capital Market·USD·Closed

VRDNNASDAQ·USD·Closed

$18.92

−4.92%

$18.92

−$0.98 (4.92%)

52W Range

27thpctl

Volume

0.41×avg

Mkt Cap

1.70BUSD

P/E

-5.4TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

27thpctl

Volume

0.41×avg

Market Cap

1.70BUSD

P/E Ratio

-5.4TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-3.8% / yr

Operating margin-543.9%

ROIC-52.3%

Financially safe

Stretched

Debt / equity0.08×

Interest coverage-34.6×

Current ratio15.15×